BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr | ₹4,210 Cr |
What is the latest Total Current Liabilities ratio of BIOCON ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹14,334 Cr |
Mar2024 | ₹15,359 Cr |
Mar2023 | ₹8,511 Cr |
Mar2022 | ₹3,828 Cr |
Mar2021 | ₹4,210 Cr |
How is Total Current Liabilities of BIOCON Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹14,334 Cr | -6.67 | |
Mar2024 | ₹15,359 Cr | 80.46 | |
Mar2023 | ₹8,511 Cr | 122.33 | |
Mar2022 | ₹3,828 Cr | -9.08 | |
Mar2021 | ₹4,210 Cr | - |
Compare Total Current Liabilities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹48,660.1 Cr | 2% | 6% | -2.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | 2% |
6% |
-2.5% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses